Insiders · Profile

MOYES JAY M

Director at PUMA BIOTECHNOLOGY · Director at Sintx Technologies · Chief Financial Officer at MYRIAD GENETICS. Filing since 18 Oct 2006. CIK 0001191062

Company
Date
Role
Action
Shares
Amount
Of holding
12 Jun 2026
Director
Sold on a plan
22,000
$158.80K
27.4%
23 Feb 2026
Director
Bought
1,000
$2.91K
33.3%
26 Aug 2025
Director
Bought
3,000
$10.76K
opened
13 Jun 2025
Director
Sold on a plan
22,000
$74.80K
29.2%
13 Jun 2024
Director
Sold on a plan
22,000
$73.47K
50.8%
13 Jun 2023
Director
Sold on a plan
22,000
$75.97K
57.4%
16 Jun 2022
Director
Sold, plan not stated
22,858
$60.37K
37.4%
10 Jun 2021
Director
Sold, plan not stated
25,248
$286.86K
80.0%
16 Sep 2020
Director
Sold, plan not stated
9,703
$97.03K
23.5%
16 Jun 2020
Director
Sold, plan not stated
9,720
$92.34K
19.1%
15 Oct 2007
Chief Financial Officer
Sold, plan not stated
39,520
$2.18M
61.0%
13 Sep 2007
Chief Financial Officer
Sold, plan not stated
59,881
$2.83M
70.3%
12 Sep 2007
Chief Financial Officer
Sold, plan not stated
20,397
$962.58K
44.7%
15 Jun 2007
Chief Financial Officer
Sold, plan not stated
1,500
$56.60K
5.6%
9 Jan 2007
Chief Financial Officer
Sold, plan not stated
8,156
$265.07K
23.7%
20 Nov 2006
Chief Financial Officer
Sold, plan not stated
4,800
$144.00K
15.6%
17 Nov 2006
Chief Financial Officer
Sold, plan not stated
333
$9.99K
1.3%
16 Nov 2006
Chief Financial Officer
Sold, plan not stated
3,023
$90.69K
10.5%
18 Oct 2006
Chief Financial Officer
Sold, plan not stated
5,000
$135.40K
16.2%
19 decisions on file.